
Anifrolumab FDA Approval to Treat Systemic Lupus [Saphnelo February 2025 Update]
Anifrolumab (Saphnelo) is the 2nd FDA-approved biologic to treat systemic lupus erythematosus (SLE). The first biologic was belimumab (Benlysta).
This article discusses Saphnelo in detail. To compare Saphnelo and Benlysta, see my other article on this topic: lupusencyclopedia.com/saphnelo-vs-benlysta
_______________________…







